The Clinical Research Management Division under the Bureau for Research and Innovation Management, Chulabhorn Royal Academy, led by Associate Professor Dr. Juthamanee Suttisisang, Acting Deputy Secretary-General of the Chulabhorn Royal Academy, along with Assistant Professor Dr. Danupol Nuntajit, Director of the Bureau for Research and Innovation Management, Dr. Chumon Punthunane, and staff from the Clinical Research Management Division, recently conducted a study visit to International BioService Co., Ltd.
The delegation was warmly welcomed by Dr. Poranee Puranachote, Executive Director, and the executive team of International BioService Co., Ltd. The company operates as a clinical research center adhering to Good Clinical Practice (GCP) standards, offering comprehensive bioequivalence research services. These studies compare drug concentration levels in the bloodstream following the administration of reference and generic drug products in healthy volunteers. All research activities are conducted in accordance with Good Laboratory Practice (GLP) standards.International BioService Co., Ltd. is accredited as a bioequivalence study center by both the Thai Food and Drug Administration (FDA) and Malaysia’s National Pharmaceutical Regulatory Agency (NPRA).
This site visit aimed to explore and exchange ideas, knowledge, skills, and expertise in comprehensive bioequivalence research conducted under internationally recognized quality systems. The objective is to support the expansion of clinical research services, particularly in pharmacokinetic and bioequivalence studies. The visit took place at the company’s facility on the 4th floor of the Golden Jubilee Medical Center, Mahidol University
